used in the RCTs were atorvastatin 80 mg, lovastatin 20 to 40 mg, pravastatin 40 mg, rosuvastatin 20 mg, and simvastatin 40 mg.
The moderate doses were atorvastatin 10 mg, pravastatin 10 to 20 mg, and rosuvastatin 10 mg, all administered once daily.
The included statins were connected in a network, as shown in Figure 2.
The final model reached a posterior mean residual deviance of 34.46 (the number of data points was 34), indicating a very good fit of
the model. The estimated effects from the pairwise metaanalyses were comparable with the results of the network meta-analysis, suggesting no evidence of inconsistency.